홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
MLTX
#2247
MoonLake Immunotherapeutics Class A Ordinary Shares
18.780
0
USD
+1.90%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.90%
월간 변동
+9.00%
6달 변화
+96.44%
년간 변동율
+96.44%
이전 종가
18.430
0
Open
18.780
0
Bid
Ask
Low
18.780
0
High
18.780
0
양
87
마켓
주식
헬스케어
MLTX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
11.93 M
11.93 M
39.15 M
62.87 M
63.28 M
71.73 M
—
Valuation ratios
Enterprise value
—
—
561.39 M
3.37 B
3.29 B
686.56 M
6 B
Price to earnings ratio
—
—
-6.49
-81.58
-28.65
-3.73
-39.79
Price to sales ratio
—
—
995.06
19.31 K
-80.7 K
1 418.42
-132.71 K
Price to cash flow ratio
—
—
-5.79
-68.38
-29.2
-4.33
-42.25
Price to book ratio
—
—
6.62
5.9
7.62
2.79
6.17
EBITDA 비율에 대한 기업 가치
—
—
-26.63
-203.49
-72.13
-10.35
-101.81
Profitability ratios
Return on assets %
—
-0.04
-0.65
-0.07
-0.25
-0.54
-0.51
Return on equity %
—
0.64
-0.73
-0.07
-0.26
-0.75
-0.7
Return on invested capital %
—
—
-427.73
-1 699.61
-2 635.87
-2 843.87
-2 987.24
Gross margin %
—
—
100
100
100
100
400
Operating margin %
—
—
-20 K
-35.73 K
339.19 K
-40.87 K
133.9 K
EBITDA margin %
—
—
-19.9 K
-35.62 K
336.01 K
-40.34 K
133.28 K
Net margin %
—
—
-15.36 K
-23.77 K
281.93 K
-37.95 K
113.7 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.93
0.21
9.98
51.59
21.11
9.27
55.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
0
0
-0
0
0
Solvency ratios
Debt to assets ratio
0
0
—
—
—
0.18
0.67
Debt to equity ratio
0.01
0
—
—
—
0.25
0.91
Long term debt to total assets ratio
0
0
—
—
—
0.17
0.65
Long term debt to total equity ratio
0.01
0
—
—
—
0.24
0.89
Per share metrics
Operating cash flow per share
—
-0
-1.9
-0.87
-1.85
-3.04
-3.08
EBIT per share
—
—
-2.2
-1.1
-2.28
-3.79
-3.84
EBITDA per share
—
—
-2.2
-1.1
-2.25
-3.75
-3.8
Total debt per share
—
0
—
—
—
1.17
4.76
Cash per share
—
0
2.46
10.4
7.13
6.11
26.44
Net current asset value per share
—
0
2.61
10.47
7.54
6.54
28.24
Tangible book value per share
—
-0.02
1.67
10.09
7.11
4.72
21.32
Working capital per share
—
-0.01
2.34
10.26
7.19
5.84
25.96
Book value per share
—
-0.02
1.67
10.09
7.11
4.72
21.32
뉴스
문레이크, IL-17 데이터에 힘입어 목표 주가 상향 - Clear Street
Clear Street raises Moonlake stock price target on IL-17 data
문레이크, axSpA 잠재력에 Cantor Fitzgerald 투자의견 재확인
Cantor Fitzgerald reiterates Moonlake stock rating on axSpA potential
문레이크, H.C. 웨인라이트 목표가 40달러로 상향
Moonlake Immunotherapeutics stock price target raised to $40 by H.C. Wainwright on trial results
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
문레이크, 긍정적 axSpA 임상 데이터에 주가 급등
MoonLake stock surges on positive axSpA trial data
문레이크, InvestingPro 공정가치 분석 후 63% 급등